Form 4: USPH Director Buys 4,000 Shares

Kathleen A. Gilmartin, a director at U.S. Physical Therapy Inc., purchased 4,000 shares of common stock at $69 per share.

Summary

• Kathleen A. Gilmartin, a Director of U.S. Physical Therapy Inc. (USPH), acquired 4,000 shares of common stock.
• The transaction occurred on November 20, 2025, at a price of $69 per share.
• Following this purchase, Ms. Gilmartin beneficially owns a total of 24,786 shares of USPH common stock.
• The reported transaction was made pursuant to a Rule 10b5-1(c) plan.
• Her total beneficial ownership includes 471 restricted shares granted under the Company's Amended and Restated 2003 Stock Incentive Plan, which will vest on March 6, 2026, contingent on her continued board membership.

Sentiment

Score: 7

Explanation: The director's purchase of company stock is generally viewed as a positive signal, indicating confidence in the company's future performance and valuation. The transaction being under a 10b5-1 plan suggests a pre-planned, rather than opportunistic, acquisition.

Positives

• A director's open market purchase of company stock can signal confidence in the company's future prospects.
• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-planned acquisition.

Risks

• The vesting of 471 restricted shares is contingent on continued board membership until March 6, 2026.

Future Outlook

The filing itself does not contain explicit forward-looking statements or guidance from the company, beyond the vesting date of restricted stock.

Industry Context

This Form 4 reports an insider transaction, which is a routine disclosure. It does not provide broader industry context or trends for the physical therapy sector. However, insider buying can sometimes be seen as a positive signal within the industry.

Comparison to Industry Standards

• This filing is a standard insider trading report and does not contain information for comparison to industry-specific operational or financial benchmarks.

Related Party Transactions

• Kathleen A. Gilmartin, a director, purchased 4,000 shares of common stock from the open market.
• Kathleen A. Gilmartin holds 471 restricted shares granted under the Company's Amended and Restated 2003 Stock Incentive Plan.

Stakeholder Impact

• Shareholders: The director's purchase could be interpreted as a positive signal, potentially boosting investor confidence.

Next Steps

• The 471 restricted shares held by Kathleen A. Gilmartin are scheduled to fully vest on March 6, 2026, provided she remains a member of the Board of Directors.

Key Dates

Recommendation

The purchase of 4,000 shares by a director at $69 per share, even under a 10b5-1 plan, indicates management confidence in the company's valuation. While a positive signal, this single transaction alone does not provide sufficient fundamental data to warrant a 'buy' or 'strong buy' recommendation without further analysis of the company's financial performance, market conditions, and strategic outlook. It primarily reinforces a 'hold' position for existing investors and suggests monitoring for potential investors.

Keywords

USPH, U.S. Physical Therapy Inc., Insider Trading, Form 4, Stock Purchase, Director, Kathleen A Gilmartin, Equity Acquisition, Rule 10b5-1